New Mexico House Passes Bill to Reject Some FDA Restrictions on Terminal Patients

SANTE FE, N.M. (March 15, 2017) – A New Mexico bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients unanimously passed the House last week. Introduced by Rep. Rebecca Dow (R-Grant), House Bill 228 (HB228) would give…

Continue ReadingNew Mexico House Passes Bill to Reject Some FDA Restrictions on Terminal Patients

New Mexico Committee Passes Bill to Reject Some FDA Restrictions on Terminal Patients

SANTE FE, N.M. (Feb. 21, 2017) – A New Mexico bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients passed an important House committee yesterday. Introduced by Rep. Rebecca Dow (R-Grant), House Bill 228 (HB228) would give…

Continue ReadingNew Mexico Committee Passes Bill to Reject Some FDA Restrictions on Terminal Patients

New Mexico Bill Would Reject Some FDA Restrictions on Terminal Patients

SANTE FE, N.M. (Jan. 30, 2016) – A bill introduced in the New Mexico House sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Rep. Rebecca Dow (R-Grant), House Bill 228 (HB228) would give terminally ill patients access…

Continue ReadingNew Mexico Bill Would Reject Some FDA Restrictions on Terminal Patients